Moderna has suffered its second PMCPA rebuke in quick succession. Days after ruling Moderna had brought discredit on the ...

CAMBRIDGE, MA and TAIPEI, TAIWAN / ACCESSWIRE / September 30, 2024 / Moderna, Inc. (Nasdaq:MRNA) and Cenra Healthcare, the sales and marketing ...

Moderna, Inc. (NASDAQ:MRNA) today announced that the first participant in the U.S. has been dosed in the Nova 301 Trial, a pivotal Phase 3 randomized clinical trial evaluating the efficacy, safety, ...

In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...

The newest update to the COVID-19 vaccine reached pharmacies as infections in Indiana began to rise. Members of our audience ...

Moderna (MRNA) closed at $66.83 in the latest trading session, marking a +1.64% move from the prior day. This change outpaced the S&P 500's 0.42% gain on the day. Meanwhile, the Dow experienced a rise ...

Stock markets will end the third quarter rewarding investors with record-breaking returns. The S&P 500 added another 5% in Q3 ...

Estes Park Health will host COVID and flu vaccine clinics this Thursday and on Oct. 10. Appointments are available every 10 minutes from 8 a.m. through 4:20 p.m. with a lunch break from noon to 12:30 ...

Track the latest bird flu vaccine news, investments, and deals as biotechs respond to rising U.S. cases with innovative ...

Good morning! What would you buy if you earned $305 million in one year? Maybe I'd have a different color KitchenAid mixer for every season. Bird flu: ...

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Metagenomi, Inc. ("Metagenomi" or the ...

Dr. Robert Langer, Co-Founder of Moderna, Joins Scientific Advisory Board of Klotho Neurosciences, Inc. (KLTO) ...